An observational study in Hip Osteoarthritis and Knee Osteoarthritis, sponsored by Lund University. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-04.
Sponsored by Lund University · Observational
This study will compare outcomes of two different delivery methods (Face-to-face and digitally) of first-line treatment for hip and knee osteoarthritis.
According to international guidelines, exercise and education should constitute the first-line intervention for people with knee and hip osteoarthritis (OA) and have been shown to be effective in reducing OA symptoms regardless of disease severity. To implement those guidelines, the Better Management of Patients with OsteoArthritis (BOA), a face-to-face concept including education and an option to exercise, has been developed and are offered at primary care clinics in Sweden since 2008. However, traditional face to face interventions present barriers, such as limited access and lack of flexibility, which may limit the patients' adherence with the interventions. In an effort to overcome such barriers, a digital self-management program (Joint Academy) that is based on the BOA concept started in 2014. Although, both delivering methods have been reported to reduce OA symptoms in patients with hip and/or knee OA, little is known whether the results of digital interventions are comparable with traditional face-to-face rehabilitation programs. In this retrospective register-based study we will compare the outcomes of the two different modalities of first-line treatment delivery (face-to-face vs digitally) after 3 months program participation using data from the BOA and Joint Academy registers. Main outcome will be self-reported change in pain between baseline and three months follow-up and secondary outcomes will be change in self-reported walking difficulties, willingness for joint surgery and health-related quality of life between baseline and three months follow-up.
Statistical analysis In this study we will include all participants in the digital program fulfilling the eligibility criteria outlined below (n >2000). These participants will be matched 1:1 to participants in the BOA register using the propensity scoring approach. The minimum clinically important difference is typically considered to be one unit on a 0-10 NRS scale. To obtain a 95% confidence interval for the between-group difference with a width of at most 0.5 units (i.e. very precise) in a sample with a typical standard deviation of 1.5, with 99% probability, we will need \~630 patients in total.
We will use observational data to emulate an equivalence trial comparing the effect on joint pain of a digitally delivered first-line intervention and of an in-person delivered first line intervention for people with OA of the hip or knee. In order to establish equivalence between the interventions the pain change after the intervention should differ of less than 1-point on a 0-10 NRS pain scale. This cut off was selected based on previous work identifying 1-point change as the MCID in people with OA. The main outcome will be analyzed using a propensity score matching approach. We will estimate the propensity score using a logistic regression model, in which we will regress the treatment status on the observed baseline characteristics of the participants. The characteristics to include in the propensity score will be selected using the disjunctive cause criteria, including factors in the analysis identified as causes of treatment allocation(exposure) and/or the pain change (outcome). We will use nearest neighbor matching to select controls (BOA participants) whose propensity score is closest to that of the treated subject. Furthermore, we will use an optimal matching strategy to minimize the total within-pair difference of the propensity score. Within-pair differences in main outcome will be analysed using a paired t-test. Finally, we will adjust the analysis for baseline pain in order to increase the precision of the estimates and minimize the regression to the mean effect
642 studies on the registry are indexed under Osteoarthritis, Hip; 122 are open to participants now.
This study's enrollment of 6,946 is above the median of 135 across 159 observational studies indexed under Osteoarthritis, Hip.
Browse Osteoarthritis, Hip studies →Lund University is the lead sponsor of 234 studies on the registry; 36 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Individuals with a clinical diagnosis of hip or knee osteoarthritis that have participated for three months in either digitally or face-to-face osteoarthritis management will be included
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Participants enrolled in the digitally delivered osteoarthritis managament program (Joint Academy register)
Other: Three months of digitally delivered osteoarthritis treatment
Participants enrolled in the face-to-face delivered osteoarthritis managament program (BOA-register)
Other: Three months of face-to-face delivered osteoarthritis treatment
Digitally delivered osteoarthritis management including education and exercise and weight control if needed
Face-toface delivered osteoarthritis management including education and exercise and weight control if needed
Pain assessed with the Numeric Rating Scale (NRS)
The NRS comprises an 11-point scale where 0 indicates no pain and 10 indicates the worst possible pain.
Time frame: Change from baseline to three months
Walking difficulties
Dihotomous reply, yes/no
Time frame: Change from baseline to three months
Willingness for surgery
Dihotomous reply, yes/no
Time frame: Change from baseline to three months
Health-related quality of life
Healt-related quality of life will be assessed with the EuroQol - 5 dimension descriptive system (EQ-5D-3L) (Index 0-1). A higher EQ-5D-3L index indicates better health-related quality of life.
Time frame: Change from baseline to three months
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — De-identified IPD for primary and secondary outcomes will be made available upon reasonable request.
Supporting information: Statistical analysis plan
Time frame: SAP is available at Lund University website: https://lucris.lub.lu.se/admin/editor/dk/atira/pure/modules/unifiedprojectmodel/external/model/project/editor/upmprojecteditor.xhtml?id=97180259
Data sharing details ↗ · lucris.lub.lu.se
Ran from Mar 2021 to primary completion in Mar 2021, 0 months.
Of 51 non-industry observational studies under Osteoarthritis, Hip, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 59. This study's 0 months is below that.
Counting every sponsor, half of 82 studies reached it within 55 months; a quarter within 14 and three quarters within 113.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.